Gallina John E 4

What Happened John E. Gallina, a director of CVS Health Corp., was issued 582 shares on 2026-03-19 as an award/other acquisition. The shares were valued at $71.86 each, for a total of $41,823. This was a compensation issuance (award/retainer), not a market purchase or sale.

Key Details

• Transaction date and price: 2026-03-19; 582 shares at $71.86 per share (total $41,823).
• Transaction type/code: A — Grant/award or other acquisition.
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Footnote: The shares "consist of common stock issued in payment of a pro rata semi‑annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan."
• Filing timeliness: Report filed 2026-03-20 for a 2026-03-19 transaction (filed the next day; appears timely).

Context This issuance represents routine director compensation (retainer paid in stock) rather than a directional buy or sell by the insider. Such awards are common and do not by themselves indicate the director's view on the company's near‑term stock performance.